Article
Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers.
Clinical genetics - 1 Jan 2014
Laitman Y, Vaisman Y, Feldman D, Helpman L, Gitly M, Paluch Shimon S, Berger R, Cohen L, Narod S A, Friedman E
Abstract excerpt
The frequency of BRCA1 and BRCA2 mutations is higher in Israel than in almost all other countries. One strategy to reduce the burden of hereditary breast and ovarian cancers is to offer genetic testing followed by risk-reducing surgery (mastectomy and salpingo-oophorectomy) for mutation carriers. The extent to which Israeli women who carry mutations undergo these surgeries is not well characterized. Israeli women...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.